Xenotransplantation

British Medical Bulletin

Volumn 55, Issue 2, 1999, Pages 446-459

  Morris, Peter J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC ANTIBODY; GALACTOSE;

GENETIC ENGINEERING; GRAFT REJECTION; HUMAN; IMMUNOLOGICAL TOLERANCE; ORGAN DONOR; PRIORITY JOURNAL; REVIEW; SWINE; XENOTRANSPLANTATION;

ACUTE DISEASE; ANIMALS; GRAFT REJECTION; HUMANS; RETROVIRIDAE INFECTIONS; SWINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 0032857086     PISSN: 00071420     EISSN: None     Source Type: Journal    
DOI: 10.1258/0007142991902367     Document Type: Review

References (69)

1. Hamilton D. Kidney transplantation: a history. In: Morris PJ, ed. Kidney Transplantation: Principles and Practice, 4th edn. Philadelphia: Saunders, 1994: 1-7
2. Reemstma K, McCracken BH, Schlegal JU et al. Renal heterotransplantation in man. Ann Surg 1964; 160; 384-XX
3. Auchincloss H. Xenogeneic transplantation. A review. Transplantation 1988; 46: 1-20
4. Auchincloss H. Xenografting: a review. Transplant Rev 1990; 4: 14-27
5. Bach FH, Dalmasso G, Platt JL. Xenotransplantation: a current perspective. Transplant Rev 1992; 6: 163-75
6. Bach FH, Auchincloss H, Robson SC. Xenotransplantation. In: Bach FH, Auchincloss H, eds. Transplantation Immunology. New York: Wiley-Liss, 1995; 305-38
7. Bach FH, Ferran C, Soares M et al. Modification of vascular responses in xenotransplantation: inflammation and apoptosis. Nat Med 1997; 3: 944-8
8. McKenzie IFC, Stocker J, Ting A, Morris PJ. Human lympho-cytotoxic and haemagglutinating activity against sheep and pig cells. Lancet 1968; ii: 386-7
9. Galili U, Shohet SB, Kobrin E, Stults CLM, Macher BA. Man, apes and old world monkeys differ from other mammals in the expression of α-galactosyl epitopes on nucleated cells. J Biol Chem 1988; 263: 17755-62
10. Sandrin M, Vaughan HA, McKenzie IFC. Identification of Gal(α1,3)Gal as the major epitope for pig-to-human vascularised xenografts. Transplant Rev 1994; 8: 134-49
11. Minanov OP, Itescu S, Neethling FA et al. Anti-Gal IgG antibodies in sera of newborn humans and baboons and its significance in pig xenotransplantation. Transplantation 1997; 63: 182-6
12. Minanov OP, Artrip JH, Szabolcs M et al. Triple immunosuppression reduces mononuclear cell infiltration and prolongs graft life in pig-to-newborn baboon cardiac xenotransplantation. J Thorac Cardiovasc Surg 1998; 115: 998-1006
13. Lambrigts D, Sachs DH, Cooper DK Discordant organ xenotransplantation in primates: world experience and current status. Transplantation 1998; 66: 547-61
14. Pascher A, Poehlein C, Stangl M et al. Application of immunoapheresis for delaying hyperacute rejection during isolated xenogeneic pig liver perfusion. Transplantation 1997; 63: 867-75
15. Taniguchi S, Neethling FA, Korchagina EY et al. In vivo immunoadsorption of antipig antibodies in baboons using a specific Gal(alpha)1-3Gal column. Transplantation 1996; 62: 1379-84
16. Kozlowski T, Lerino FL, Lambrigts D et al. Depletion of anti-Gal(alpha)1-3Gal antibody in baboons by specific alpha-Gal immunoaffinity columns. Xenotransplantation 1998; 5: 122-31
17. Lin SS, Kooyman DL, Daniels LJ et al. The role of antural anti-Gal alpha 1-3Gal antibodies in hyperacute rejection of pig-to-baboon cardiac xenotransplants. Transpl Immunol 1997; 5: 212-8
18. Xu Y, Lorf T, Sablinski T et al. Removal of anti-porcine antural antibodies from human and nonhuman primate plasma in vitro and in vivo by a Gal-alpha-1-3-Gal-beta-1-4-beta-Glc-X immunoaffinity column. Transplantation 1998; 65: 172-9
19. Simon PM, Neethling FA, Taniguchi S et al. Intravenous infusion of Gal-alpha 1-3Gal oligosaccharides in baboons delays hyperacute rejection of porcine heart xenografts. Transplantation 1998; 65: 346-53
20. Nagasaka T, Kobayashi T, Muramatsu H et al. Alpha-galactosyl oligosaccharides conjugated with polyethylene glycol as potential inhibitors of hyperacute rejection upon xenotransplantation. Biochem Biophys Res Commun 1997; 232: 731-6
21. McKane W, Lee J, Preston R et al. Polymorphism in the human anti-pig natural antibody repertoire: implications for antigen-specific immunoadsorption. Transplantation 1998; 66: 626-33
22. Kobayashi T, Taniguchi S, Neethling FA et al. Delayed xenograft rejection of pig-to-baboon cardiac transplants after cobra venom factor therapy. Transplantation 1997; 64: 1255-61
23. Romanella M, Aminian A, Adam WR, Pearse MJ, d'Apice AJ. Involvement of both the classical and alternate pathways of complement in an ex vivo model of xenograft rejection. Transplantation 1997; 63: 1021-5
24. Pruitt SK, Kirk AD, Bollinger RR et al. The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts. Transplantation 1994; 57: 363-XX
25. Pruitt SK, Bollinger RR, Collins BH et al. Effect of continuous complement inhibition using soluble complement receptor Type I on survival of pig-to-primate xenografts. Transplantation 1997; 63: 900-2
26. Platt JL, Logan JS. Use of transgenic animals in xenotransplantation. Transplant Rev 1996; 10: 69-77
27. Van Denderen BJ, Pearse MJ, Katerelos M et al. Expression of functional decay-accelerating factor (CD55) in transgenic mice protects against human complement-mediated attack. Transplantation 1996, 61: 582-8
28. Yannoutsos N, Ijzermans JN, Harkes C et al. A membrane cofactor protein transgenic mouse model for the study of discordant xenograft rejection. Genes Cells 1996; 1 409-19
29. Cowan PJ, Shinkel TA, Witort EJ, Barlow H, Pearse MJ, d'Apice AJ. Targeting gene expression to endothelial cells in transgenic mice using the human intercellular adhesion molecule 2 promoter. Transplantation 1996; 62: 155-60
30. Cowan PJ, Somerville CA, Shinkel TA et al. High-level endothelial expression of human CD59 prolongs heart function in an ex vivo model of xenograft rejection. Transplantation 1998; 65: 826-31
31. Zaidi-A, Schmoeckel M, Bhatti F et al. Life-supporting pig-to-primate renal xenotransplantation using genetically modified donors. Transplantation 1998; 65: 1584-90
32. Pascher A, Poehlein C, Storck M et al. Immunopathological observations after xenogeneic liver perfusions using donor pigs transgenic for human decay-accelerating factor. Transplantation 1997; 64: 384-91
33. Schmoeckel M, Nollert G, Shahmohammadi M et al. Transgenic human decay accelerating factor makes normal pigs function as a concordant species. J Heart Lung Transplant 1997; 16: 758-64
34. Daggett CW, Yeatman M, Lodge AJ et al. Swine lungs expressing human complement-regulatory proteins are protected against acute pulmonary dysfunction in a human plasma perfusion model. J Thorac Cardiovasc Surg. 1997; 113: 390-8
35. Storck M, Abendroth D, Prestel R et al. Morphology of hDAF (CD55) transgenic pig kidneys following ex-vivo hemoperfusion with human blood. Transplantation 1997; 63: 304-10
36. Byrne GW, McCurry KR, Martin MJ, McClellan SM, Platt JL, Logan JS. Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage. Transplantation 1997; 63: 149-55
37. Schmoeckel M, Nollert G, Shahmohammadi M et al. Prevention of hyperacute rejection by human decay accelerating factor in xenogeneic perfused working hearts. Transplantation 1996; 62: 729-34
38. Diamond LE, McCurry KR, Martin MJ et al. Characterization of transgenic pigs expressing functionally active human CD59 on cardiac endothelium. Transplantation 1996; 61: 1241-9
39. Yeatman M, Daggett CW, Parker W et al. Complement-mediated pulmonary xenograft injury: studies in swine-to-primate orthotopic single lung transplant models. Transplantation 1998; 65: 1084-93
40. Lin SS, Weidner BC, Byrne GW et al. The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants. J Clin Invest 1998; 101: 1745-56
41. Daggett CW, Yeatman M, Lodge AJ et al. Total respiratory support from swine lungs in primate recipients. J Thorac Cardiovasc Surg 1998; 115: 19-27
42. Schmoeckel M, Nollert G, Shahmohammadi M et al. Transgenic human decay accelerating factor makes normal pigs function as a concordant species. J Heart Lung Transplant 1997; 16: 758-64
43. Tearle RG, Tange MJ, Zannettino ZL et al. The alpha-1,3-galactosyltransferase knockout mouse. Implications for xenotransplantation. Transplantation 1996; 61: 13-9
44. Cohney S, McKenzie IF, Patton K et al. Down-regulation of Gal alpha(1,3)Gal expression by alpha1,2-fucosyltransferase: further characterization of alpha1,2-fucosyltransferase transgenic mice. Transplantation 1997; 64: 495-500
45. Shinkel TA, Chen CG, Salvaris E et al. Changes in cell surface glycosylation in alpha 1,3-galactosyltransferase knockout and alpha1,2-fucosyltransferase transgenic mice. Transplantation 1997; 64: 197-204
46. Chen CG, Salvaris EJ, Tomanella M et al. Transgenic expression of human alpha1,2-fucosyltransferase (H-transferase) prolongs mouse heart survival in an ex vivo model of xenograft rejection. Transplantation 1998; 65: 832-7
47. Sepp A, Skacel P, Lindstedt R, Lechler RI. Expression of alpha-1,3-galactose and other type 2 oligosaccharide structures in a porcine endothelial cell line transfected with human alpha-1,2-fucosyltransferase cDNA. J Biol Chem 1997; 272: 23104-10
48. Osman N, McKenzie IF, Ostenried K, Ionnou YA, Desnick RJ, Sandrin MS. Combined transgenic expression of alpha-galactosidase and alpha1,2-fucosyltransferase leads to optimal reduction in the major xenoepitope Gal alpha(1,3)Gal. Proc Natl Acad Sci USA 1997; 94: 14677-82
49. Van Denderen BJ, Salvaris E, Tomanella M et al. Combination of decay-accelerating factor expression and alpha1,3-galactosyltransferase knockout affords added protection from human complement-mediated injury. Transplantation 1997; 64: 882-8
50. Cowan PJ, Chen CG, Shinkel TA et al. Knock out of alpha 1,3-galactosyltransferase or expression of alpha1,2-fucosyltransferase further protects CD55-and CD59-expressing mouse hearts in an ex vivo model of xenograft rejection. Transplantation 1998; 65: 1599-604
51. Bracy JL, Sachs DH, Lacomini J. Inhibition of xenoreactive natural antibody production by retroviral gene therapy. Science 1998; 281: 1845-7
52. Chitilian HV, Laufer TM, Stenger K, Shea S, Auchincloss Jr H. The strength of cell-mediated xenograft rejection in the mouse is due to the CD4+ indirect response. Xenotransplantation 1998; 5: 93-8
53. Homan WP, Williams KA, Fabre JW, Millard PR, Morris PJ. Prolongation of cardiac xenograft survival in rats receiving cyclosporin A. Transplantation 1981; 31: 164-6
54. Miyatake T, Sato K, Takigami K et al. Complement-fixing elicited antibodies are a major component in the pathogenesis of xenograft rejection. J Immunol 1998; 160: 4114-23
55. Lin Y, Vandeputte M, Waer M. Natural killer cell-and macrophage-mediated rejection of concordant xenografts in the absence of T and B cell responses. J Immunol 1997; 158: 5658-67
56. Vallee I, Guillaumin JM, Thibault G et al. Human T lymphocyte proliferative response to resting porcine endothelial cells results from an HLA-restricted, IL-10-sensitive, indirect presentation pathway but also depends on endothelial specific co-stimulatory factors. J Immunol 1998; 161: 1652-8
57. Minanov OP, Artrip JH, Szabolcs M et al. Triple immunosuppression reduces mononuclear cell infiltration and prolongs graft life in pig-to-newborn baboon cardiac xenotransplantation. J Thorac Cardiovasc Surg 1998; 115: 998-1006
58. Sablinski T, Gianello PR, Bailin M et al. Pig-to-monkey bone marrow and kidney xenotransplantation. Surgery 1997; 121: 381-91
59. Yang YG, deGoma E, Ohdan H et al. Tolerization of anti-Gal alpha 1-3 Gal natural antibody-forming B cells by induction of mixed chimerism. J Exp Med 1998; 187: 1335-42
60. Starzl TE, Fung J, Tzakis A et al. Baboons to human liver transplant. Lancet 1991; 341: 65-71
61. Hammer C, Linke R, Wagner F, Diefenbeck M. Organs from animals for man. Int Arch Allergy Immunol 1998; 116: 5-21
62. Patience C, Takenchi Y, Weiss RA Infection of human cells by an endogenous retrovirus of pigs. Nat Med 1997; 3: 282-6
63. Martin U, Kiessig V, Blusch JH et al. Expression of pig endogenous retrovirus by primary porcine endothelial cells and infection of human cells. Lancet 1998; 352: 692-4
64. Patience C, Patton GS, Takeuchi Y et al. No evidence of pig DNA or retroviral infection in patients with short-term extracorporeal connection to pig kidneys. Lancet 1998; 352: 699-701
65. Heneine W, Tibell A, Switzer WM et al. No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts. Lancet 1998; 352: 695-9
66. Martin U, Steinhoff G, Kiessig V et al. Porcine endogenous retrovirus (PERV) was not transmitted from transplanted porcine endothelial cells to baboons in vivo. Transpl Int 1998; 11: 247-51
67. Meng XJ, Purcell RH, Halbur PG et al. A novel virus in swine is closely related to the human hepatitis E virus. Proc Natl Acad Sci USA 1997; 93: 9860-5
68. Allan JS, Broussard SR, Michaels MG et al. Amplification of simian retroviral sequences from human recipients of baboon liver transplants. AIDS Res Hum Retroviruses 1998; 14: 821-4
69. Daar AS. Ethics of xenotransplantation: animal issues, consent, and likely transformation of transplant ethics. World J Surg 1997; 21: 975-82